SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yosid who wrote (520)4/23/1998 2:09:00 AM
From: Jim Mac   of 1754
 
That's true, but look at the relative valuations of LCAV and LVCI compared to the operating fundamentals. Either LCAV is overpriced, or LVCI is underpriced. LZRCF is overpriced now, but I like what they're doing, and if I'd known TLC was on NASDAQ last Fall, I would have bought it near $8. Those guys are hardcore, and if anyone can stomp in this industry, they can. I like them as much as LaserVision, but LaserVision is much more reasonably priced now.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News